Make your money go further for just 25p per day

Bioventix (AIM:BVXP) – cracking update and results significantly ahead  

04/09/2015 · Bioventix PLC (BVXP) 

The UK creator and engineer of antibodies for applications in clinical diagnostics, which we commented on in April 2015, has announced a short yet highly positive trading update covering the year ending 30 June 2015. This really is a unique little business on AIM.

The update confirmed that the core business remains robust and that revenues for the year are expected to be in excess of £4.2m (2014:£3.5m) and given the relatively modest and fixed cost base, profits before tax will be significantly ahead of market expectations. 

House broker expectations were previously for pre-tax profit of £2.7m and eps of 44.8p which have now been upgraded to £3.1m and 50.8p, that’s quite…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Bioventix PLC

Bonkers Bargain soars on takeover - more to go for?

29/03/2021 · Company Insights

Shares in an earlier Bonkers Bargain soar on a takeover approach, but there appears to be…


Coronavirus impact: 19 Oct - boohoo tumbles (again) but others impress

19/10/2020 · Company Insights

While boohoo’s travails continue to dominate the news on AIM, several other fast-growing companies covered here…


More Company Insights

Agronomics: illustrates the crazy nature of the market

13/05/2021 · Agronomics

Bonkers Bargains: Where there’s muck…

13/05/2021